LEAP Testing Service
 |
|
The
ASTM D6499 Assay is one of the most frequently performed tests at Guthrie. |
TESTS OFFERED
The LEAP Testing
Service offers services in determining the extractable proteins in latex
products. There are several tests that can be performed on latex products
including: the ASTM D6499-07 and Lowry Assay with Precipitation according to
(Lowry ASTM D5712-05), Latex Fingerprint Assay, Western Blot Analysis, and
Specialized Studies.
Click on assay for a brief description of the protocol.
 |
* ASTM
D6499-07 (Inhibition ELISA)
This assay uses an Inhibition ELISA to quantitate antigenic latex protein in product extracts. In an Inhibition ELISA, soluble antigens in the extract compete for binding to specific anti-latex antibodies and block antibody binding to latex antigen immobilized on the surface of the assay plate. |
 |
* ASTM
D5712-05 Lowry with Precipitation
Quantitatively measures the level of extractable proteins in latex products using a precipitation step to decrease the levels of interfering substances
(5712-05 reporting limit
42ug/gm). |
 |
ASTM
D7427-08. Allergen ELISA
The ASTM
D7427-08 is a set of 4 ELISA tests for specific latex allergens. This assay uses
monoclonal antibodies to quantitate the allergen levels
of Hev
b1, Hev b3 and Hev b5 and Hev b6.02. This assay differs from the ASTM D6499 method in that
it measures allergen content as apposed to antigenic content. The allergenic
proteins are the ones that are recognized by IgE antibodies and elicit an
allergic or anaphylactic response. This assay is very useful when you need to
know the allergen level. The 6499 assay is used to quantitate all the latex
proteins that elicit an antibody response. Because the 7427 assay uses
monoclonal antibodies it is highly specific for the latex protein allergens. As
the 6499 assay uses polyclonal sera there is the possibility that it may cross
react with epitopes found on other proteins. (Please call or Email us to find
out about availability and pricing.) |
 |
Western Blot Analysis
Qualitatively assesses the molecular weight distribution of antigenic protein in latex extracts by separating the proteins with SDS-PAGE, transferring them to a nitrocellulose or PVDF membrane and then identifying the latex proteins using anti-latex antibody. |
 |
Residual Glove Powder
Analysis ASTM D 6124-06
Quantitatively measures
the amount of powder on the surface of gloves. The assay is performed by washing
the glove with dH2O. The wash is then filtered through a glass fiber filter. The
change in weight of the filter reflects the amount of powder present on the
glove. Results are given in terms of mg powder/glove. The ASTM has set limits
for the amount of powder on the surface of gloves. These standards are:
<1mg/glove for "Powder Free" gloves, <10mg/glove fore
Examination gloves, and <15mg/glove for Surgical gloves. |
|
ASTM
D 7558-09
- Chemical
Sensitivity
The
chemical sensitivity assay was developed to quantify residual chemicals
(vulcanization accelerators) used in the manufacturing of latex devises.
Individuals can develop allergic contact dermatitis while being exposed to these
residual chemicals. Monitoring the residual chemicals can give customers useful
data to lower the amount of expose to these chemicals in their final products. |
|
Guayule
Latex ELISA
This
assay uses an Inhibition ELISA to quantitate antigenic Guayule latex protein in
product extracts. In an Inhibition ELISA, soluble antigens in the extract
compete for binding to specific anti-latex antibodies and block antibody binding
to latex antigen immobilized on the surface of the assay plate. |
|
|
Latex
in Air Analysis ELISA
This
assay applies the D6499-07 assay in conjunction with air monitoring techniques.
Suspect Latex contaminated air is filtered through air monitoring cassettes
which is then is extracted from the filters and then analyzed utilizing the
D6499-07 assay. |
 |
Specialized Studies
Provides customers with specialized studies using state of the art research techniques. Studies may include: development of new tests, specialized product testing, or research protocols under confidentiality agreements. Study protocols and costs would be outlined in a proposal after the study goals have been fully evaluated. |
|
* - A2LA
accredited assays. |